Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or major widespread health crisis, though it is better positioned in some technical areas than before COVID-19. Assessments from bipartisan commissions, the Government Accountability Office (GAO), CDC, WHO-linked evaluations, and experts consistently describe a mixed picture: meaningful progress in stockpiles, surveillance, data systems, and some medical countermeasures (MCMs), offset by persistent gaps in leadership/coordination, sustained funding, state/local capacity, workforce, supply chains, and political/societal factors.[1][2]
Progress Since COVID-19
The US has taken concrete steps informed by COVID-19 lessons:
These enhance detection speed, MCM availability for known threats, and basic response logistics compared to early 2020.
Persistent Gaps and Vulnerabilities
Independent reviews highlight that progress is incomplete and fragile:
GAO lessons emphasize better advance planning (roles, exercises, capabilities), partner collaboration, clear communications, data sharing, integrity controls for relief programs, leveraging existing systems, and flexibilities (e.g., telehealth). Many recommendations remain unimplemented.[2]
Bottom Line and Outlook
The US has stronger stockpiles, data tools, some MCM pipelines, and institutional memory than in 2019, enabling faster initial responses to contained or moderate threats (as seen with mpox elements or respiratory seasons). However, for a severe, novel, highly transmissible pathogen with high mortality—or concurrent crises—it is not adequately prepared. Structural fragmentation, inconsistent funding/political will, local capacity gaps, and incomplete lesson implementation leave major vulnerabilities. Experts and commissions warn that without sustained, bipartisan investment in core public health infrastructure, leadership clarity, One Health approaches (human-animal-environment), domestic production, R&D for platform technologies (e.g., 100-day vaccines), and trust-building, outcomes could again be suboptimal.[1]
Preparedness is a continuous process, not a destination. Ongoing monitoring of threats like H5N1, exercises, full implementation of open recommendations, and stable multi-year funding would improve readiness. Assessments evolve with new data, administrations, and budgets; current consensus from nonpartisan and bipartisan sources is that significant work remains.
Citations (10)
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Assessments from bipartisan commissions, the Government Accountability Office (GAO), CDC, WHO-linked evaluations, and experts consistently describe a mixed picture: meaningful progress in stockpiles, surveillance, data systems, and some medical countermeasures (MCMs), offset by persistent gaps in…”
- https://www.gao.gov/products/gao-24-107175
Backs: “Assessments from bipartisan commissions, the Government Accountability Office (GAO), CDC, WHO-linked evaluations, and experts consistently describe a mixed picture: meaningful progress in stockpiles, surveillance, data systems, and some medical countermeasures (MCMs), offset by persistent gaps in…”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “It has supported responses to H5N1, mpox, and other incidents by deploying PPE, antivirals, vaccines, and other supplies.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “CDC launched platforms for real-time data integration, forecasting/outbreak analytics (e.g., Center for Forecasting and Outbreak Analytics), and improved respiratory illness tracking.”
- https://iris.who.int/bitstream/handle/10665/380155/9789240105409-eng.pdf?sequence=1sask
Backs: “A 2024 Joint External Evaluation (JEE) of IHR core capacities was completed, noting strengths while recommending improvements.”
- https://ghsindex.org/country/united-states/
Backs: “A 2024 Joint External Evaluation (JEE) of IHR core capacities was completed, noting strengths while recommending improvements.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Attention and investment have waned as the acute crisis faded.”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Attention and investment have waned as the acute crisis faded.”
- https://www.ft.com/content/2ff195fc-b89d-401d-acfa-800aff68bb80
Backs: “Experts note insufficient broad-spectrum antivirals and rapid MCM platforms for novel pathogens.”
- https://www.forbes.com/sites/maryroeloffs/2026/05/18/world-isnt-ready-for-another-pandemic-and-moving-in-the-wrong-direction-who-report-says/
Backs: “Global preparedness has also stagnated or declined in key areas per some WHO-linked assessments.”